The mitochondrial-derived peptide MOTS-c enhances exercise capacity and lowers obesity, insulin resistance, and other disease processes including osteoporosis while promoting metabolic homeostasis and life. - According to research, MOTS-c is helpful for the following: - Muscle Metabolism - Fat Metabolism - Insulin Sensitivity - Osteoporosis - Longevity - Heart Health

Pegylated Mechano Growth Factor (PEG MGF) is a subtype of IGF-1 (insulin-like growth factor-1), which promotes the division of myoblasts and permits the fusion and maturation of muscle fibers. The following therapeutic benefits of PEG-MGF have been shown through research: - Ability to re-build muscles - Ability to make new muscle cells - Neuroprotective effects - Cardioprotective effects - Promotes wound healing and tissue regeneration - Promotes bone injury recovery - Lowers total body fat and cholesterol - Increases immunity

Retatrutide is a peptide characterized as a triple GGG agonist, targeting three key incretin receptors: GLP-1R (Glucagon-Like Peptide-1 Receptor), GIPR (Gastric Inhibitory Peptide Receptor), and GCGR (Glucagon Receptor). This multifaceted approach allows retatrutide to exert a comprehensive influence on metabolic processes, including enhancing satiety signals, slowing gastric emptying, and increasing the breakdown of stored fats and glycogen.

Semaglutide is a modified form of the naturally present GLP-1 peptide, which is recognized for its ability to regulate blood sugar and boost insulin release. Studies indicate that Semaglutide could also have positive effects on cardiac, hepatic, and pulmonary health, as well as potentially mitigating the impact of Alzheimer's disease. Additionally, it has been found to effectively curb hunger by slowing down the emptying of the stomach and limiting the movement of the intestines. As a GLP-1 analog, it is designed to both enhance insulin production and inhibit the release of glucagon in a manner dependent on glucose levels. Semaglutide has demonstrated the largest weight loss of any obesity medication to date with reductions of approximately 15% of initial weight at 68 weeks.

Setmelanotide works by activating pathways in the brain to promote weight loss by decreasing appetite and caloric intake, and increasing energy expenditure.

Tesamorelin, is a growth-hormone-releasing hormone (GHRH) analogue. Recent research and clinical trials have established that it has the following benefits: - Increases natural productions of HGH (human growth hormone) - Increases IGF-1 (Insulin Growth Factor – 1) without altering glucose parameters - Reduced triglycerides - Reduced Visceral Adipose Tissue (VAT) - Reduced Carotid Intima Media Size (cIMT) - Improved cognition in adults over the age of 60 - Anti-aging  effects - Restoring Growth Hormone - Preserving Lean Muscle Mass Tesamorelin is now being tested in clinical trials for the treatment of HIV-associated lipodystrophy. (Lipodystrophy is characterized by excessive accumulation of fat not just in the abdominal region but also in other parts of the body.) It is also being researched for its ability to improve peripheral nerve health and slow the progression of mild cognitive impairment/dementia.

Tesofensine significantly supports weight loss, body fat reduction, and appetite reduction. It increases an individual's resting energy expenditure by stimulating the fat oxidation process. Below are its main effects: - Reduced body fat / Weight loss - Appetite suppression - Improved libido - Better sleep quality - Improved cognitive function

Developed primarily to combat type 2 diabetes, Tirzepatide is a synthetic form of gastric inhibitory polypeptide (GIP) that also possesses glucagon-like peptide-1 (GLP-1) functionality. This dual action enables it to not only reduce blood sugar levels and enhance insulin sensitivity but also promote weight loss and increase feelings of fullness. Moreover, Tirzepatide has demonstrated protective effects on the cardiovascular system.

TRH (thyrotropin releasing hormone) is a small peptide hormone produced in the hypothalamus. Research on TRH has shown improvement in thyroid function as well as multiple other effects: - Antidepressant activity - Aging-Reversing - Free radical reduction - Regulation of the autonomic nervous system - Loss of fat deposits - Lowering of sugar and triglyceride levels